NCCN Guidelines® Insights: Myeloproliferative Neoplasms, Version 2.2026
Journal of the National Comprehensive Cancer Network · 2026-07 · 24 (7)
DOI: 10.6004/jnccn.2026.0034 ↗Kurz gefasst
Leitlinie in der Zeitschrift Journal of the National Comprehensive Cancer Network, 2026-07. Verfasst von Aaron T Gerds und 32 weiteren Autor:innen. Beteiligte Einrichtung: 1Case Comprehensive Cancer Center/University Hospitals Seidman Cancer Center and Cleveland Clinic Taussig Cancer Institute. Hauptthemen laut MEDLINE: Myeloproliferative Disorders. Die Arbeit nennt 57 Literaturangaben.
Abstract (Originalsprache)
The Philadelphia chromosome-negative myeloproliferative neoplasms (MPN) are a group of heterogenous hematologic malignancies characterized by the proliferation of blood cells and consist of myelofibrosis, polycythemia vera, and essential thrombocythemia. The NCCN Guidelines for MPN were developed as a result of meetings convened by a multidisciplinary panel with expertise in MPN, with the aim of providing recommendations for the comprehensive care of adults with these diseases. The panel of experts convenes at least once a year to discuss requested changes to the Guidelines and to evaluate emerging data. These Guideline Insights focus on some of the recent updates for myelofibrosis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- 1Case Comprehensive Cancer Center/University Hospitals Seidman Cancer Center and Cleveland Clinic Taussig Cancer Institute.
- 2Stanford Cancer Institute.
- 3Fox Chase Cancer Center.
- 4City of Hope National Medical Center.
- 5Dana-Farber/Brigham and Women's Cancer Center.
- 6Memorial Sloan Kettering Cancer Center.
Zitieren
APA
Gerds, A. T., Gotlib, J., Abdelmessieh, P., Ali, H., Castells, M., Chernak, B. J., Espinoza-Gutarra, M. R., Fein Revell, R., Green, S., Gundabolu, K., Hexner, E., Jain, T., Jamieson, C. H., Khan, I., Kuykendall, A. T., Madanat, Y. F., Masarova, L., McMahon, B., Mohan, S. R., …, & Hochstetler, C. (2026). NCCN Guidelines® Insights: Myeloproliferative Neoplasms, Version 2.2026. Journal of the National Comprehensive Cancer Network, 24(7). https://doi.org/10.6004/jnccn.2026.0034
Vancouver
Gerds AT, Gotlib J, Abdelmessieh P, Ali H, Castells M, Chernak BJ, et al. NCCN Guidelines® Insights: Myeloproliferative Neoplasms, Version 2.2026. Journal of the National Comprehensive Cancer Network. 2026;24(7). doi:10.6004/jnccn.2026.0034
BibTeX
@article{Gerds2026,
author = {Gerds, Aaron T and Gotlib, Jason and Abdelmessieh, Peter and Ali, Haris and Castells, Mariana and Chernak, Brian J and Espinoza-Gutarra, Manuel R and Fein Revell, Ruth and Green, Steven and Gundabolu, Krishna and Hexner, Elizabeth and Jain, Tania and Jamieson, Catriona H and Khan, Irum and Kuykendall, Andrew T and Madanat, Yazan F and Masarova, Lucia and McMahon, Brandon and Mohan, Sanjay R and Nadiminti, Kalyan V and Oh, Stephen and Palmer, Jeanne and Patel, Ami B and Patel, Anand A and Podoltsev, Nikolai and Rein, Lindsay and Salit, Rachel and Sehl, Mary and Talpaz, Moshe and Wadleigh, Martha and Wall, Sarah A and Bergman, Mary Anne and Hochstetler, Cindy},
title = {NCCN Guidelines® Insights: Myeloproliferative Neoplasms, Version 2.2026},
journal = {Journal of the National Comprehensive Cancer Network},
year = {2026},
volume = {24},
number = {7},
doi = {10.6004/jnccn.2026.0034}
}
EUVIMED